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Maturational changes in rabbit renal cortical phospholipase A2 activ-
ity. Several studies have demonstrated that the neonatal kidney has a
markedly attenuated response to parathyroid hormone (PTH); however,
the cause for this blunted response is unknown. PTH stimulated cAMP
production by 215 18% in neonatal proximal tubule suspensions
compared to a 35 7% increase in adult proximal tubules. Thus, neonatal
proximal tubules have functioning PTH receptors and a greater adenylate
cyclase response than the adult segment. In adult proximal tubules, PTH
stimulates phospholipase A2 (PLA2) activity and the inhibition of Na,K-
ATPase activity by PTH is blocked by inhibitors of PLA2. We examined
whether maturational changes in renal cortical activity could play a role in
the attenuated response to PTH in the neonatal proximal tubule. Com-
pared to adults, neonates had a lower renal cortical cytosolic PLA2
(cPLA2) activity, assessed as the release of 14C-arachidonic acid (AA)
from labeled phosphatidyl choline (0.44 0.10 vs. 0.74 0.06% '4C-AA
released/mm/mg protein, P < 0.05) and microsomal PLA2 activity (0.32
0.03 vs. 1.20 0.13% '4C-AA released/mm/mg protein, P < 0.001). The
protein abundance of cPLA2 was not different between the neonatal and
adult renal cortex as assessed by immunoblot assay. Thus, the difference in
activities must be due to a difference in regulation of cPLA2. Annexin I
(lipocortin 1) has been shown to inhibit PLA2 activity by binding to
phospholipid substrate. Annexin I protein abundance was higher in
neonatal than in adult renal cortex (P < 0.001). Thus, the lower activity of
PLA2 in the neonatal tubules may be due in part to higher expression of
annexin 1. PLA2 activation by PTH, 8-bromo-cAMP and PMA was
assessed as 3H-AA release from prelabeled suspensions of neonatal and
adult proximal tubules. PTH (10 M), 8-bromo-cAMP (10 M) and PMA
(5X i0 M) significantly increased 3H-AA release from adult tubules (P <
0.05) but had no effect on neonatal tubules (P = NS). Thus, PTH,
8-bromo-cAMP and PMA stimulated PLA2 in adult but not neonatal
proximal tubules. In conclusion, the maturational changes in renal cortical
PLA2 activity may be a factor in the blunted response of neonatal proximal
tubules to PTH.
The phospholipases A2 (PLA,) are a group of enzymes that
catalyze the hydrolysis of phospholipids at the sn-2 position
resulting in the formation of a free fatty acid and a lysophospho-
lipid [1]. The cytoplasmic form of phospholipase A2 (cPLA2) is
the rate-limiting, regulated step in the release of arachidonic acid
(AA) in many signal transduction pathways [1, 21. Once arachi-
donic acid is formed, it can serve as a second messenger directly
or can be metabolized by one of its oxidation pathways to form a
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metabolite that can then act as a second messenger [2]. These
compounds can also act in a paracrine fashion to affect neighbor-
ing cells [21. Recently, it has been recognized that many of the
hormones that affect renal function activate PLA2 in their signal
transduction pathway [1, 2].
Parathyroid hormone (PTH) affects many of the transport
systems in the proximal tubule including the Na-H exchanger,
Na-Pi cotransporter and the Na,K-ATPase through activation of
the adenylate cyclase—protein kinase A and phospholipase
C—protein kinase C pathways [3, 4]. Recently, PTH inhibition of
proximal tubule Na,K-ATPase was shown to be mediated by PLA2
[5]. PTH stimulated the release of arachidonic acid (AA) from
proximal tubules in suspension and the inhibitory effect of PTI-]
on the Na,K-ATPase was blocked by inhibition of PLA2 [5].
Addition of AA or its metabolite, 20-HETE, reproduced the
Na,K-ATPase inhibition of PTH [5]. Thus, release of AA by PLA2
and formation of its subsequent metabolite, 20-HETE, appear to
play a role in the inhibitory effect of PTH on the Na,K-ATPase.
The kidneys of young, growing mammals avidly retain phos-
phate and have a blunted response to the phosphaturic effect of
PTH [6]. One-day-old human infants reabsorb virtually all of the
filtered phosphate [7, 8]. The tubular reabsorption of phosphate
decreases by the third day of life, but does not fall to adult values
until adolescence. When infants were given parathyroid gland
extracts, the increase in phosphate excretion was negligible at one
day of age and was minimal at three days of age when compared
to adults [8]. Thus, there is evidence in humans that the immature
kidney is refractory to the phosphaturic effects of PTH.
The reason for the blunted response of the immature kidney to
the phosphaturic effect of PTH remains unclear. In rats, infusion
of PTH in both young and mature animals increased the urinary
cxcrction of cAMP but the phosphaturic effect was seen only in
the adults [9]. The infusion of PTH into isolated perfused kidneys
from young guinea pigs had no effect on phosphate excretion bul
caused a greater increase in excretion of cAMP than from adult
kidneys [10]. Thus, in animal studies it appears that the adenylate
cyclase response to PTH is fully developed and thus could not
explain the unresponsiveness of the kidney to the phosphaturic
effect of PTH. This suggests that the blunted response of the
immature kidney to PTH must he due to a maturational change in
the signaling pathway downstream from cAMP. One of the
pathways that may play a role in the blunted response is PLA2.
The purpose of the present study was to examine the matura-
tion of PLA2 activity in the rabbit renal cortex and its role in the
72 Sheu et al: Maturational changes in renal PL4, activity
signal transduction pathway for PTH. The development of prox-
imal tubule transport and its regulation by glucocorticoids have
been extensively studied in the rabbit [11, 12]. Thus, the rabbit
renal cortex would be a suitable tissue for examining the matura-
tion of PLA2 and its regulation by glucocorticoids.
METHODS
Preparation of cytosol and microsomes
Cytosolic and microsomal fractions of renal cortex from neo-
natal (7 to 14 days old) and adult New Zealand white rabbits were
prepared as described by Nakamura et a! [13]. Briefly, the kidneys
were removed immediately after sacrifice and the cortex was
excised and placed in 20 ml of cold (4°C) homogenization buffer
containing: 250 m sucrose, 50 mivi Tris-HC1 (pH 7.5), 1 mM
EDTA, 1 mit EGTA, 0.1 mt PMSF, 20 /.LM leupeptin, 20 /LM
pepstatin and 2 tg/mI aprotinin. The tissue was homogenized for
90 seconds using a Polytron homogenizer. The crude homogenate
was centrifuged for 10 minutes at 900 X g at 4°C. The pellet was
discarded and the supernatant centrifuged for 20 minutes at
9,000 X g at 4°C. The resulting supernatant was centrifuged for 60
minutes at 100,000 X g at 4°C to separate the cytosolic fraction
(supernatant) from the microsomal fraction (pellet).
The microsomes were resuspended by passing them through a
21 gauge needle 15 to 20 times in cold (4°C) extraction buffer
containing: 1 M KCI, 50 mrvi Tris-HCI (pH 7.5), 1 mivi EDTA and
1 mM EGTA. The microsomes were incubated in the extraction
buffer at 4°C for 60 minutes. The suspension was then centrifuged
for 60 minutes at 100,000 >< g at 4°C. The pellet was discarded and
the supernatant was used for the microsomal protein fraction.
Phospholipase A2 assay
Phospholipase A2 activity was assayed as the release of '4C-
arachidonic acid from liposomes as described by Hildebrandt and
Albanesi [14]. Liposomes were made using 1-palmitoyl-2-[1-14C]-
arachidonylphosphatidylcholine (0.01 mCi/0.2 ml; New England
Nuclear, Wilmington, DE, USA) and diarachidonyl-phosphatidyl-
choline (Sigma Chemical Co., St. Louis, MO, USA). The cold PC
(85 tl of 10 mg/mI in ethanol) was combined with radiolabeled PC
(57 fd) in 0.5 ml of CH3CI:MeOH (2:1 by volume). This mixture
was dried under nitrogen, resuspended in homogenization buffer
and sonicated (Model G 112 SPI; Laboratory Supplies Co.,
Hicksville, NY, USA) at 70°C for 10 minutes (until the mixture
was clear). The liposomes were stored at 4°C and were resoni-
cated just prior to each assay.
The homogenization buffer was used as the incubation buffer
for the zero calcium studies. Otherwise, the total calcium concen-
tration was increased to 4.5 m so that the free calcium concen-
tration would be 2.5 m greater than the EDTA and EGTA
concentrations. The ionized calcium concentration was measured
and found to be 2.6 m. The cytosolic and microsomal fraction
were then added with the buffer to a final volume of 500 ILl. The
ratio of cytosolic protein or microsomal protein to buffer was
varied so that the final protein concentration was approximately
0.5 mg/mI. Care was taken to ensure that the total calcium in these
assay mixtures was the same. The non-enzymatic release of
14C-AA was determined by incubating liposomes without protein
in the incubation buffer (± Ca2) for 30 minutes at 37°C.
The assay was initiated by adding 20 jd of liposomes to the
assay mixture and briefly vortexing. The mixture was then allowed
to incubate for 30 minutes at 37°C and the reaction was termi-
nated by the addition of 2 ml of CH3CI:MeOH:acetic acid (9:4:1
by volume). The organic phase was dried under nitrogen, resus-
pended in 40 p1 of chloroform and spotted onto a 20x20 cm silica
gel thin layer chromatography (TLC) plate. The TLC solvent
phase was hexane:diethyl ether:acetic acid (75:25:4 by volume).
The plate was dried, sprayed with EN3HANCE (New England
Nuclear) and autoradiography was performed for detection of the
lipid samples. The locations of the spots were verified by running
standards with the same solvent system and exposing the gel to
iodine vapors. The phospholipid and arachidonic acid spots were
cut out for liquid scintillation counting. The results were then
calculated as the percent of counts in the free arachidonic acid
spot over the total counts for that sample and expressed as
percent released/mm/mg protein.
Dexamethasone treatment
Glucocorticoids have been shown to have marked effects on
maturation of renal function [11, 12]. Glucocorticoids are also
known to inhibit PLA2 activity in many tissues [15, 16]. However,
it is not known how this inhibitory action of glucocorticoids on
PLA2 will interact with their effect on renal maturation. Thus, the
next set of experiments was designed to address this interaction.
The glucocorticoid, dexamethasone, was employed because of its
use in many of the maturation studies [11, 12].
Adult animals were treated with either vehicle or dexametha-
sone at 60 ILg/100 g body wt given subcutaneously every 12 hours
for a total of five doses. Neonates were treated with the same dose
(high dose group) or with 10 g/lOO g body wt (low dose group)
given subcutaneously once a day for four days. This is a protocol
used previously in our laboratory for studying the effects of
glucocorticoids on maturation of the proximal tubule [17, 18]. The
last dose of dexamethasone was given two hours prior to sacrifice.
Preparation of proximal tubule suspensions
Tubule suspensions were prepared using the technique devel-
oped by Weinberg et al [19] as modified by our laboratory [20].
Briefly, renal cortex was excised from kidneys from neonatal (7 to
14 days old) and adult New Zealand White rabbits and digested
with collagenase (Worthington). The tissue was then centrifuged
in a 50% Percoll solution, which separated the denser proximal
tubules from other structures in the cortex. The tubules were then
rinsed and resuspended in media (Dulbecco's modified Eagle's
medium Ham's F-12 supplemented with 15 mM NaHCO5 and 10
mM hepanoic acid, gassed with 95% 02/5% CU2, pH 7.4) at 37°C.
These proximal tubule suspensions were used to measure cAMP
production and activation of PLA2.
Effect of PTH on cAMP production
To determine whether rabbit neonatal proximal tubules have
functional PTH receptors, the effect of PTH (1—34) on cAMP
production was assessed. Proximal tubule suspensions from neo-
nates (7 to 14 days old) and adult rabbits were prepared as
described above, then suspended in media at 37°C. At time zero,
either vehicle (0.9% saline) or i0 M PTH (1—34) (Sigma) was
added. After 15 minutes of incubation, the tubules were lysed with
10% TCA. The samples were then centrifuged at 4°C at 2000 X g
for 15 minutes. The supernatant was removed for cAMP deter-
mination and the pellet was assayed for protein using BCA
(Pierce).
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The supernatant was extracted four times with water equili-
brated ether, then the aqueous phase was dried under nitrogen
then resuspended in assay buffer provided in the Amersham
cAMP EIA kit (Amersham). The samples were then diluted 1:10
with assay buffer prior to the cAMP determination. Directions
were followed in the kit for determining the standard curve and
the sample concentrations of cAMP. Absorbance was read at 450
nm on a Titertek Multiskan MC!340 microtiter plate reader
(Finland).
Phospholipase A2 activation studies
In experiments where the activation of PLA2 by PTH, 8-bromo-
cAMP and PMA was examined, proximal tubule suspensions were
prepared as described above. The tubules were labeled with
3H-arachidonic acid (New England Nuclear) by incubating in
media at 37°C for 30 minutes with 3H-AA. The tubules were
rinsed and incubated for an additional 30 minutes as a chase and
then rinsed and resuspended in media. Tubules were then incu-
bated at 37°C for 15 minutes with either vehicle (PBS, pH 7.4),
10 M parathyroid hormone (1—34), 1O M 8-bromo-cAMP,
5X108 M phorbol myristate acetate (PMA) or 10_6 M mellitin.
Mellitin was used as a positive control to ensure that the
preparation was viable. Two volumes of an ice-cold ultrafiltrate-
like solution were added to stop the reaction and total lipids were
extracted using the technique of Bligh and Dyer [21]. The lipid
samples were dried under nitrogen, reconstituted in 40 1.d of
chloroform and spotted on 20x20 cm TLC plates. The TLC
solvent system was diethyl ether:hexane:acetic acid (70:30:1 by
volume). The areas containing 3H were identified by autoradiog-
raphy as phospholipids, diacylglycerol, free fatty acids, and trig-
lycerides, and were cut out and assayed by liquid scintillation
counting. The positions of these lipids have been previously
verified by running standards using this solvent system and
identified by exposure to iodine vapors. The fraction of free fatty
acid (which represents arachidonic acid) in each sample was then
calculated as the free fatty acid counts divided by the total counts
(phospholipid + diacylglycerol + free fatty acid + triglyceride) and
was expressed as a percentage. The total counts in these experi-
ments ranged from 100,000 cpm to 300,000 cpm. In the vehicle
treated controls, the percent of counts in the free fatty acid
fraction ranged from 0.73% to 9.42%. Because of the wide
variation in the controls, the results were analyzed in a paired
fashion. PLA2 activation was determined by comparing the per-
cent arachidonic acid in the experimental sample with the 15-
minute vehicle treated sample.
Immunoblotting
Renal cortex was dissected from neonatal and adult rabbits and
placed in 15 ml of ice-cold isolation buffer (300 ifiM D-mannitol,
16 mM Hepes, 5 miu EGTA, pH 7.4 with solid Tris-base, 2 ig/ml
aprotinin, 2 g/ml leupeptin and 100 tg!ml PMSF). Samples were
homogenized on ice with a Polytron homogenizer for two repeti-
tions of 15 times for three seconds each time. One milliliter
aliquots were centrifuged for 20 minutes at 15,000 X g at 4°C. The
supernatant was removed, assayed for protein content (BCA
Protein Assay Reagent; Pierce), and stored in 100 jg aliquots at
—80°C. SDS/PAGE gels were made according to manufacturer's
instructions (Bio-Rad Mini-PROTEAN II). Fifty micrograms of
total protein in a final volume of 30 jrl of 1 x loading buffer (1.7
mM Tris, pH 6.8, 1% SDS, 10% glycerol, 1% 2-mercaptoethanol,
pinch bromphenol blue) were loaded in each sample lane along
with Prestained Molecular Weight Standards (Sigma). Proteins
were transferred onto PVDF (Immobilon) for one hour using
Bio-Rad Mini-Transblot electroblotting apparatus.
Blots were preincubated in Blotto [5% nonfat dried milk, 0.05%
Tween-20 in autoclaved Tris-buffered saline (10 mvi Tris-Cl, pH
8.0, 150 m'vi NaCl)1 for one hour, incubated with the primary
antibody [anti-annexin I (1:500; Transduction Laboratories)]
overnight and then with the secondary Ab [HRP-conjugated
anti-mouse monoclonal Ab (1:10,000; ECL kit, Amersham)] for
one hour. Detection was done with Boehringer-Mannheim
Chemiluminescence Western blotting kit per the manufacturer's
instructions and densitometry was performed.
Statistical analysis
Results from the neonates and adults were compared using
analysis of variance. If the analysis of variance was significant,
comparisons between the groups were performed using the Bon-
ferroni adjustment. In experiments where only two groups were
studied, comparisons were made using an unpaired I-test.
RESULTS
Maturation of PLA2
The first set of experiments was designed to measure the
activity of PLA2 in cytosolic and microsomal fractions of neonatal
and adult renal cortical tissue. These results are shown in Figure
I and Table 1. Both cytosolic and microsomal PLA2 activities in
the control neonates were significantly lower than the adult
controls (P < 0.001). There was little nonenzymatic release of
'4C-AA (0.020 0.004%/mm that was less than 10% of the total
'4C-AA released in the studies with cytosolic or microsomal
proteins). Thus, there was a significant increase in PLA2 activity
with maturation.
There are several forms of PLA2 in the cytosol that differ in
their calcium dependence and may mature at different rates.
Thus, the calcium dependence of the cortical PLA2 was also
determined in the neonates and adults. These results are shown in
Table 1. In the neonates, the activity of cytosolic PLA2 in the zero
calcium buffer was 28% of the activity in the calcium replete
buffer. In the adults, the removal of calcium reduced the activity
of cytosolic PLA2 to 29% of the control value. Although the
calcium free activity in the adult renal cortex was almost twice the
activity in the neonates, the difference was not statistically signif-
icant (P = 0.075). The microsomal PLA2 activity in the zero
calcium buffer was 36% and 38% of control in the neonates and
adults, respectively. The difference between the adult and neona-
tal PLA2 microsomal activity was statistically significant (P
0.001). This indicates that approximately two-thirds of the PLA2
activity in the renal cortex is calcium dependent and one-third is
calcium independent, and that these proportions do not change
significantly with maturation.
cPLA2 protein abundance
The next experiment determined if the difference in cPLA2
activity was due to a difference in protein abundance. As shown in
Figure 2, the abundance of cPLA2 as assessed by immunoblot
assay is not different between neonates and adults (densitometry:
neonates. 9,250 1,110, N = 4; vs. adults, 8,780 420, N 3;
P NS). Because the protein abundance is not different between
-Neo Adult
F cPLA, protein abundance in neonatal and adu
was harvested and electrophoresis performed
ods. Densitometry demonstrated no difference i
ween the neonates (N = 4) and adults (N = 3).
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Fig. 1. PLA2 activity from neonatal and adult renal cortex. Animals were
treated with either vehicle (control group) or with low dose dexametha-
sone (10 sgI100 g body wt each day for 4 days) or with high dose
dexamethasone (dex; 60 g/l00 g body wt twice a day for 5 doses). PLA2
activity was assayed in the cytosolic (A) and microsomal fractions (B) by
incubating with 1-palmitoyl-2-[1- '4C]-arachidonylphosphatidylcholine
containing liposomes and is expressed as the release of 14C-arachidonic
acid. In A, the analysis of variance is F 5.8; in B, F 7.0. < 0.05
comparing adults to all other groups. There was no difference between
three neonatal groups.
the two groups, the difference in activity must be due to a
difference in the regulation of cPLA2.
Annexin 1 protein abundance
The next experiment determined if annexin 1, a protein that
inhibits PLA2 activity by limiting access to substrate [22, 23],
played a role in the development of PLA2 activity in the rabbit
renal cortex. The result is displayed in Figure 3. As can be seen,
the relative protein abundance of annexin I was higher in the
neonate than in the adult. Densitometry showed that the amount
in the neonates was significantly higher than the adults (neonates,
Table 1. Calcium dependence of renal cortical PLA2 activity (%
release/mm/mg/protein)
Zero calciuma N 4.5 mi calcium N
Neonatal cytosol 0.120 0.018 7 0.433 0.067 9
Adult cytosol
Neonatal microsome
0.216 0.049
0.113 0.003c
6
3
0.742 0.057
0.315 0.031'
7
5
Adult microsome 0.457 0.036 6 1.201 0.133 7
a All results were different from 4.5 m calcium (P < 0.005)h Different from adults (4.5 m calcium) (P <0.05)
Different from adult microsomes (zero calcium) (P < 0.001)
Fig. 2. Immunoblot of cPL 2 protein a   lt
renal cortex. Tissue was harv sted and el t ormed as
described in the methods. Densito etx tr t d no dif  in
protein abundance bet ee  t t s (  4) 3).
Fig. 3. Immunoblot of annexin 1 protein abundance in neonatal and
adult renal cortex. Tissue was harvested and Western blot as described in
the methods. Densitometry showed that the annexin 1 protein abundance
in the neonate (N = 4) was higher than the adult (N = 3).
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66,500 6,700, N = 4; vs. adults, 12,100 4,500, N = 3; P <
0.001). These results suggest that annexin 1 may play a role in the
lower PLA2 activity in the neonate.
Effects of dexamethasone on PLA2 activity
We have previously demonstrated that dexamethasone will
hasten the maturation of transport processes in the neonatal
proximal tubule [15]. Glucocorticoids have also been shown to
decrease PLA2 activity in many tissues [15, 16]. The next set of
experiments examined the effect of dexamethasone on renal
cortical PLA2 activity in neonates and adults. The results are
shown in Figure 1. Dexamethasone significantly decreased PLA2
activity in the adult cytosolic and microsomal fractions but had no
effect on the neonates.
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Neonatal tubules Adult tubules
Fig. 4. Effect of iO M PTH (1-34, bovine) on cAMP production in
neonatal and adult proximal tubule suspensions. Tubule suspensions
were prepared as described in the methods then incubated with either
vehicle (0.9% saline) or 10 M PTH. cAMP was assayed by competitive
protein binding and is expressed as pmol cAMP/mg protein. N = 4 for
neonates and adults. P < 0.005 vs. neonatal control; P < 0.005 vs. adult
control.
Effect of PTH on cAMP production
To confirm that rabbit neonatal proximal tubules have func-
tional PTH receptors, the response of cAMP to PTH was deter-
mined in neonatal and adult proximal tubule suspensions. These
results are shown in Figure 4. Adult proximal tubules (N = 4) had
a 35 7% increase in the cAMP content after stimulation with
iO M PTH. Neonatal proximal tubules (N = 4) demonstrated a
much larger increase (215 18%, P = 0.0001) versus adult in
their cAMP content after stimulation with iO7 M PTH. Thus,
rabbit neonatal proximal tubules demonstrate functioning PTH
receptors and have a larger stimulation in cAMP than adult
tubules.
PLA2 activation
The last set of experiments determined the activation of PLA2
by PTH, 8-bromo-cAMP and PMA in the neonatal and adult
proximal tubule suspensions. These results are shown in Figure 5.
Because of variation of the control values in this preparation, the
data were analyzed using repeat measures analysis of variance.
PTH stimulated release of 3H-AA from the adult tubules hut not
from the neonatal tubules. In the adults, 8-bromo-cAMP and
PMA also significantly increased the release of 3H-AA while they
had no effect in the neonates (Fig. 5). Mellitin, a direct agonist of
PLA2 that was used as a positive control, stimulated release of
3H-AA in both neonatal tubules (control 0.64 0.08% vs. mellitin
26.15 0.65%; N = 4, P < 0.0001) and adult tubules (control
0.41 0.08% vs. mellitin 9.73 2.67%; N = 4, P < 0.05). Thus,
PLA2 in both the neonatal and adult preparations responded to
direct stimulation by mellitin. The ability of PLA2 to respond to
physiologic stimuli such as PTH, the second messenger, 8-bromo-
cAMP, and PKC activation by PMA is developmentally regulated.
PTH 8-bromo-cAMP
I I
*1
Fig. 5. Activation of PLA2 in neonatal and adult proximal tubule sus-
pensions 8-bromo-cAMP and PMA. Proximal tubule suspensions from
neonatal and adult rabbits were incubated with 3H-arachidonic acid to
label the phospholipid pool. After the free arachidonic acid was washed
out, the tubules were incubated for 15 minutes with vehicle (control), iO
M PTH, 8-bromo-cAMP (l0- M) or PMA (5 X 10 M). Time zero
aliquots of tubules were analyzed so that the effect of time could be
assessed. There was no significant increase in 3H-AA release with time.
Lipids were extracted and separated by thin layer chromatography.
Results are expressed as free 3H-AA as a percent of the total labeled
lipids. N = 7 for neonates. N = 8 for adult PTH and N = 6 for adult cAMP
and PMA studies. < 0.05.
DISCUSSION
The present study examined the maturation of renal cortical
PLA2 activity. Both cytosolic and microsomal PLA2 activities were
significantly lower in the neonatal kidney than the adult kidney,
although protein abundance of cPLA2 was not different. Annexin
1 protein abundance was higher in neonatal tissue and might play
a role in the low PLA2 activity in the neonatal proximal tubule.
Thus, one possible regulator of the development of PLA2 activity
is annexin 1. Also, dexamethasone suppressed the PLA2 activity in
the adult kidney cortex but had no effect on the neonatal tissue.
PTH, 8-bromo-cAMP and PMA were able to stimulate release of
arachidonic acid from adult proximal tubule suspensions, indicat-
ing that PLA2 had been activated. None of these maneuvers were
able to stimulate release of arachidonic acid from the neonatal
proximal tubules. The adenylate cyclase resonse to PTH was
intact in the neonate indicating that the neonatal tubules have
intact PTH receptors. Thus, the immaturity of PLA2 in rabbit
renal cortical tissue may explain the lack of response in neonatal
kidneys to the phosphaturic effect of PTH.
Phospholipase A7 activity has been identified in cytosolic,
mitochondrial and microsomal fractions of rat kidneys (13]. A
high molecular weight form was recently identified and is thought
to be the eytosolic form [24j. Further characterization of the PLA2
activity showed it to be present in mesangial cells and was
regulated by epidermal growth factor, vasopressin and protein
kinase C [24—26J. Thus, it appears as though the mesangial PLA2
may be responsible for mediating the effects of various hormones
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on glomerular hemodynamics. A calcium-independent phospho-
lipase A2 has also been isolated from rabbit kidney [271. More
recently, PLA2 activity has been identified in tubules isolated from
rat kidneys and may, in part, mediate effects of hypoxia or
hormone mediated changes in epithelial transport [1, 2, 5, 28, 29].
There are several potential explanations for the maturational
increase in renal cortical PLA2 activity. The fact that protein
abundance of cPLA2 was not different suggests that the amount of
enzyme present is not a factor so that the difference in activity
must be in regulation of the enzyme. The annexins are a group of
proteins that were initially thought to be up-regulated by glu-
cocorticoids and also directly inhibit PLA2 and therefore may be
involved in the glucocorticoid induced decrease in PLA2 activity
[22, 231. Further characterization of these proteins has shown that
they bind to phospholipids and calcium [30]. Their action to
inhibit PLA2 is probably due to their ability to sequester the
substrate from the enzyme. The abundance of annexin I was
found to be much higher in the neonate than in the adult renal
cortex (Fig. 3). Thus, annexin 1 may play a role in inhibiting or
blocking the activation of PLA2 in the neonatal proximal tubule.
Another potential factor is that a number of isoforms of PLA2
have been found in the kidney [1, 2] and they may mature at
different rates. The conditions for assaying PLA2 activity in the
present study may have examined only the PLA2 isoform that
preferentially utilizes phosphtidylcholine as its substrate. Differ-
ences in phospholipid substrate may also account for maturational
changes of PLA2 activity in viva. Previous studies have examined
the phospholipid content of renal membranes during maturation
[31, 32]. There was an increase in the amount of phosphotidyl-
choline with age [31] and with glucocorticoid treatment [32].
However, neither study examined the arachidonic acid content of
the various phospholipid poois, so the impact on PLA2 activity is
unknown. Also, in the present study, the assay was performed in
vitro with the same phosphatidylcholine substrate for both neo-
nates and adults.
Although the regulation of PLA2 by glucocorticoids in adult
tissues has been known for some time [33, 34], the mechanism by
which they inhibit PLA2 activity remains unclear. Glucocorticoids
down-regulate group II PLA2 by decreasing mRNA synthesis and
post-transcriptional protein expression [16]. This has also been
demonstrated in a rat model of endotoxin shock where adminis-
tration of endotoxin up-regulates group 11 PLA2 activity [35].
Glucocorticoids were able to suppress the endotoxin induced
upregulation of PLA2 activity and mRNA abundance in this
model [35]. There is some degree of inhibition normally because
glucocorticoid deficiency due to adrenalectomy was associated
with an increase in PLA2 message abundance and activity [15].
Glucocorticoids are also known to play a large role in the
maturation of renal tubular function [11, 12, 32]. In the rabbit,
concomitant with the maturational increase in renal tubular
function, there is a rise in circulating glucocorticoid concentra-
tions [11, 12]. Thus, they might have an impact on maturation of
PLA2 regulation. In the present study, dexamethasone treatment
decreased PLA2 activity in the adult tissue but had no effect on the
neonatal activity. The explanation for these effects remains un-
clear. It is possible that the regulatory elements that down-
regulate PLA2 activity in the adult tissue are not present in the
neonates. It is also possible that the total PLA2 activity that is
measured may consist of two components: a glucocorticoid sup-
pressible component and a glucocorticoid resistant component.
This is suggested because the PLA2 activity in the adult tissue
after glucocorticoid treatment is not zero but is identical to the
neonatal activity. Thus, the neonates may not have the glucocor-
ticoid suppressible fraction.
The signaling pathway for the action of PTH in the proximal
tubule is complex and has recently been shown to include
activation of phospholipase A2 [5, 291. In proximal tubule cells
from adult rats, incubation with PTH caused a greater release of
arachidonic acid than with vehicle, indicating that PLA2 was
activated [5, 29]. The free arachidonic acid may affect transport
directly or indirectly via one of its oxidation metabolites [5]. The
inhibition of proximal tubule Na,K-ATPase by PTH was blocked
by ETYA, an inhibitor of all AA-dependent metabolic pathways,
or with 7-ethoxyresorufin, an inhibitor of the cytochrome P450
monoxygenase system that metabolizes AA. In the present study,
PTH was shown to activate PLA2 in adult proximal tubules but
not in neonatal tubules. Thus, although there is no direct evidence
that activation of PLA2 inhibits phosphate transport, the data
suggest that the lack of effect of PTH on phosphate transport in
neonatal tubules could be due to immaturity of PLA2.
Because PTH stimulates adenylate cyclase and accumulation of
cAMP, the effect of cAMP on PLA2 activity was also studied. In
many tissues, including platelets, lung, hepatocytes and mono-
cytes, cAMP appears to down-regulate PLA2 [36]. However, in
renal tissue several recent studies suggest that cAMP may stimu-
late PLA2. In rat proximal convoluted tubules, the ability of PTH
to inhibit the Na,K-ATPase was abolished by treating the tubules
with mepacrine, an inhibitor of PLA2 [371. The inhibition of
Na,K-ATPase by dopamine, fenoldapam, forskolin and dibutyryl
cAMP in rat cortical collecting tubules was also blocked by
mepacrine [37, 38]. Also, arachidonic acid metabolism was stim-
ulated in rabbit medullary thick ascending limb cells by dibutyryl
cAMP and two hormones that stimulate adenylate cyclase, salmon
calcitonin and arginine vasopressin [39]. In the present study,
8-bromo-cAMP clearly stimulated PLA2 in the adult proximal
tubules, as evidenced by the increase release of AA, while it had
no effect on the neonatal tubules.
PTH also stimulates phospholipase C which releases inositol
trisphosphate (1P3) and diacyiglycerol (DAG) [40]; the latter
stimulates protein kinase C. DAG may also serve as a substrate
for PLA2 in the production of free AA [1, 2]. Thus, another
possible explanation for changes in maturation could be the
interplay between PLC and PLA2. In OK cells, a renal cell line
that responds to PTH by decreasing phosphate uptake, activation
of PKC with DAG mimicked the effect of PTH [41]. The role of
phospholipase C and protein kinase C in signal transduction of
PTH has recently been re-examined [42]. Blocking PLC with
U-73,122 appears to block the effect of PTH on phosphate uptake
into OK cells [42]. The inhibition of the Na,K-ATPase by PKC
stimulation appears to be mediated, in part, by PLA2. Blocking
PLA2 activity with mepacrine in rat proximal tubules blocked the
Na,K-ATPase inhibition of PKC [37]. Thus, the PTH induced
stimulation of PLA2 may be mediated in part by an increase in
PKC activity. In the present study, direct activation of PKC with
PMA activated PLA2 in adult tubules but not in neonatal tubules.
Thus, the PKC pathway is unable to stimulate PLA2 in the
neonatal tubules.
The ontogeny of PLA2 activity depends on the organ being
studied and the cellular location of the PLA2 activity. In rabbit
lung tissue, initial studies indicated that PLA2 activity in the
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microsomal fraction of the tissue was highest in the fetus and
lowest in the neonate [43]. The activity then remained constant
through adulthood. In the same study, PLA2 activity from the
lysosomal fraction decreased from the fetus to the neonate, but
increased as the rabbits matured further [43]. A subsequent study
of rabbit lung PLA2 activity showed that the activity in the cytosol,
microsomes, lamellar bodies and total homogenate either re-
mained constant or decreased from the neonate to the adult [44].
The only fraction that demonstrated an increase was the mito-
chondrial fraction. In rats, intestinal PLA2 activity showed an
increase as the animals matured [45]. However, activity was
measured in a homogenate and not in subcellular fractions so it is
unclear which fraction may have been responsible for the in-
crease. Group I and group II secretoly PLA2 in the gastrointes-
tinal tract also increase with postnatal maturation [46, 47]. These
increases were also hastened by the treatment of the animal with
glucocorticoids. In the present study, there was a twofold increase
in both the cytosolic and microsomal PLA2 baseline activity.
The present study examined the maturation of renal cortical
PLA2 activity. The neonatal renal cortex had a much lower
baseline activity of PLA2 and did not show activation by PTH,
8-bromo-cAMP or PKC activation. In addition, although dexa-
methasone inhibited PLA2 in the adult renal cortex, it had no
effect on the neonatal tissue. Thus, the regulation of PLA2 in
neonatal renal Cortex is different from the adult. Annexin I may
play a role in the altered activity and regulation of PLA2 in the
rabbit kidney.
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